The Ohio State University Dermatology Biorepository

Last updated: April 2, 2024
Sponsor: Ohio State University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hidradenitis Suppurativa

Rosacea

Acne Inversa

Treatment

N/A

Clinical Study ID

NCT03146676
2010H0331
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Seen by an Ohio State University (OSU) Dermatology provider on the main UniversityHospital campus, including the James Cancer Hospital, OSU Dermatology East, OSUDermatology at the Ohio State Eye and Ear Institute, Martha Morehouse MedicalPavilion, and OSU Dermatology at Upper Arlington after the date of approval of thisprotocol
  • Ability to provide informed consent, or parent or legal guardian capable of providingconsent for child or mentally handicapped individuals
  • Willingness to participate in a research study.

Exclusion

Exclusion Criteria:

  • Inability to provide informed consent

Study Design

Total Participants: 175
Study Start date:
April 19, 2017
Estimated Completion Date:
December 31, 2030

Study Description

A variety of molecular techniques can be used to investigate diseases by analyzing protein, DNA, and RNA. Flow cytometry, Polymerase chain reaction (PCR), histology and immunohistochemistry are assays which can identify specific cell populations and provide valuable information regarding the pathologic characteristics of those populations. Flow cytometry analyzes the surface markers of cells. Histology and immunohistochemistry further characterize surface and cellular molecules and aid in the diagnosis of certain skin diseases. Gene expression profiling allows investigators to examine the genes detectable to determine the function of the cells involved, and PCR techniques are useful for the diagnosis of certain conditions and for DNA analysis.

By procuring blood, skin tissue, and swab samples from patients with and without neoplastic and inflammatory skin disorders at the time of their appointments, the hypothesize that future translational research can be conducted on such specimens using the aforementioned techniques to further understand disease mechanisms in cutaneous disorders, and to potentially discover defective function and genetic mutations within cells from patients with neoplastic and inflammatory skin disorders. By establishing a tissue bank, we aim to lay the foundation for future work that will improve our understanding of the biology and natural history of neoplastic and inflammatory cutaneous diseases.

Connect with a study center

  • OSU Dermatology West

    Columbus, Ohio 43215
    United States

    Active - Recruiting

  • OSU Dermatology East

    Gahanna, Ohio 43230
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.